June 09, 2021
Tulane University will team up with the University of Delaware on one of 15 U.S. Department of Energy projects designed to advance new technologies to decarbonize the biorefining processes used to convert organic material into fuel.
June 09, 2021
Tulane University will lead a multicenter clinical trial to study whether atrial fibrillation (AFib) patients who undergo cardiac ablation to correct an irregular heart rhythm have better long-term outcomes when taking an anti-arrhythmic drug.
June 03, 2021
A new cancer treatment that uses engineered radioactive molecules to target prostate cancer cells and inhibit tumor growth extended survival for patients with advanced prostate cancer, according to newly announced results of the VISION trial.
May 27, 2021
A Studio in the Woods has been awarded a NEA grant designed to integrate arts and culture into activities that strengthen communities economically, physically and socially.
May 18, 2021
Researchers at Tulane University School of Medicine have developed a highly sensitive blood test that can find traces of the bacteria that causes tuberculosis (TB) in infants more than a year before they develop the deadly disease, according to a study published in BMC Medicine.
May 12, 2021
Tulane University has appointed Richard Chau as its new chief investment officer (CIO). Chau, who officially began his appointment on May 11, oversees Tulane’s Investment Management Office, which is responsible for managing the university’s endowment and related long-term investment assets. The endowment is unique among the university's revenue streams because it provides perpetual support for students, both current and prospective. Chau replaces longtime CIO Jeremy Crigler, who retired last fall.
May 10, 2021
Tulane University’s School of Professional Advancement (SoPA) announced a tuition discount award of 20 percent to students enrolled in Tulane SoPA graduate or post-baccalaureate programs who have earned their undergraduate degree from a Minority Serving Institution. The tuition discount begins with the summer 2021 semester. Applications are now being accepted. To apply for the scholarship award, please visit the financial assistance page.
May 05, 2021
A team of Tulane University researchers has launched a study to better understand how children are affected by skin and hair-type discrimination as they develop into adulthood.
April 30, 2021
Tulane scientists are part of a team of researchers who have developed a smart quantum technology that could improve quantum communications systems used in the military.
April 28, 2021
A $1 million gift from Board of Tulane member Lisa Jackson, Apple Inc.’s vice president of environment, policy and social initiatives, and her husband, Kenneth, will double participation in the Newcomb-Tulane College Summer Experience (NTCSE). The program helps newly admitted students from underserved backgrounds get a head start on succeeding at Tulane before fall orientation.
April 26, 2021
Suzana Savkovic, Tulane associate professor of pathology and laboratory medicine, and a team of researchers were recently awarded a five-year, $1.6 million National Cancer Institute grant to investigate the connection between obesity and enhanced risk for colon cancer.
April 23, 2021
The final installment of the Dean’s Speaker’s Series on Anti-Racism and the Disciplines will take place April 29 with a lecture by Sarah J. Jackson, a communication studies expert.
April 21, 2021
Gary “Hoov” Hoover, the director of Tulane University’s Murphy Institute and a leading economist on issues of economic policy and its impact on inequality, is among a group of 40 Nobel Prize laureates and global innovators selected for the inaugural Nobel Prize Summit, April 26-28, 2021. Registration for the virtual summit is free and open to the public. Please click here for more information or to register for the event.
April 21, 2021
A new study co-authored by researchers at Tulane National Primate Research Center found that a vaccine currently being developed induces a robust and long-lasting immune response against SARS-CoV-2, the virus that causes COVID-19, in nonhuman primates similar to the protection provided by the Moderna vaccine.